AFP and hepatocellular carcinoma: Even though the proportion of AFP-negative was as high as 15–30% in advanced patients, the American Association for the Study of Liver Diseases updated their practice guidelines in 2011, saying that AFP was no longer recommended for the detection of early HCC [6].